Abstract: Researchers in the fields of obstetrics, gynecology, and chinese integrative medicine (CIM) were invited to share their perspectives on the most recent studies.

女性健康与中西医结合医学

[1]Andersen, A.N., Goossens, V., Gianaroli, L., et al., 2007. Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Hum. Reprod., 22(6):1513-1525.

[2]Cao, H., Han, M., Ng, E.H., et al., 2013. Can Chinese herbal medicine improve outcomes of in vitro fertilization? A systematic review and meta-analysis of randomized controlled trials. PLoS ONE, 8(12):e81650.

[3]Clifford, G.M., Smith, J.S., Aguado, T., et al., 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer, 89(1):101-105.

[4]Du, M.K., Ge, L.Y., Zhou, M.L., et al., 2017. Effects of pre-pregnancy body mass index and gestational weight gain on neonatal birth weight. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 18(3):263-271

[5]Ho, C.M., Lee, B.H., Chang, S.F., et al., 2010. Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia. Int. J. Cancer, 127(3):622-632.

[6]Horsey, K., 2006. 3 000 000 IVF babies born worldwide since 1979. Presented at the Annual Conference of the European Society of Human Reproduction and Embryology (ESHRE). Prague, Czech Republic.

[7]Jemal, A., Bray, F., Center, M.M., et al., 2011. Global cancer statistics. CA Cancer J. Clin., 61(2):69-90.

[8]Li, Y., Chen, X., Chen, S., et al., 2014. A cohort study on the impacts of pre-pregnancy maternal body mass index, gestational weight gain on neonate birth status and perinatal outcomes in Fujian province. Zhonghua Liu Xing Bing Xue Za Zhi, 35(6):635-640 (in Chinese).

[9]Liu, Y., Dai, W., Dai, X., et al., 2012. Prepregnancy body mass index and gestational weight gain with the outcome of pregnancy: a 13-year study of 292 568 cases in China. Arch. Gynecol. Obstet., 286(4):905-911.

[10]Myers, E.R., 2006. Acupuncture as adjunctive therapy in assisted reproduction: remaining uncertainties. Fertil. Steril., 85(5):1362-1363.

[11]Nygren, K.G., Andersen, A.N., 2001. Assisted reproductive technology in Europe, 1997. Results generated from European registers by ESHRE. The European IVF-monitoring programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum. Reprod., 16(2):384-391. https://doi.org/10.1093/humrep/16.2.384

[12]Oken, E., Kleinman, K.P., Belfort, M.B., et al., 2009. Associations of gestational weight gain with short- and longer-term maternal and child health outcomes. Am. J. Epidemiol., 170(2):173-180.

[13]Qu, F., Zhou, J., Ren, R.X., 2012. Effects of acupuncture on the outcomes of in vitro fertilization: a systematic review and meta-analysis. J. Altern. Complement. Med., 18(5):429-439.

[14]Schiffman, M., Wentzensen, N., Wacholder, S., et al., 2011. Human papillomavirus testing in the prevention of cervical cancer. J. Natl. Cancer Inst., 103(5):368-383.

[15]Stamnes Koepp, U.M., Frost Andersen, L., Dahl-Joergensen, K., et al., 2012. Maternal pre-pregnant body mass index, maternal weight change and offspring birthweight. Acta Obstet. Gynecol. Scand., 91(2):243-249.

[16]Wu, Y., Robinson, N., Hardiman, P.J., et al., 2016. Acupuncture for treating polycystic ovary syndrome: guidance for future randomized controlled trials. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 17(3):169-180.

[17]Yao, Y.L., Tian, Q.F., Cheng, B., et al., 2017. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV positive women. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 18(3):256-262.

[18]Ye, J., Cheng, B., Cheng, Y.F., et al., 2017. Prognostic value of human papillomavirus 16/18 genotyping in low-grade cervical lesions preceded by mildly abnormal cytology. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 18(3):249-255.

[19]Zappacosta, R., Caraceni, D., Ciccocioppo, L., et al., 2013. Implementing specificity of HPV-DNA primary screening in a successful organised cervical cancer prevention programme. Gynecol. Oncol., 128(3):427-432.